Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)

Name: Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
Published: 2022
License: Public Domain

ANRS, Emerging Infectious Diseases · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

hiv-infections

hiv infections, dolutegravir, hiv drug resistance, real life, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)

Related documents